Clinical Trial Update: Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical naltrexone ophthalmic solution for signs and symptoms of dry eye in diabetic subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Topical Naltrexone Ophthalmic Solution (naltrexone)

Snippet

Sponsor: Sassani, Joseph S., MD, MHA | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-12-02